Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • News & Views
  • Published:

Stones

The dark side of stone disease — stones do still kill

Nature Reviews Urology volume 13, pages 247–248 (2016)Cite this article

Subjects

A study investigating the mortality attributed to urolithiasis over a 15-year period has noted an increasing rate of death with a simultaneous rise in stone prevalence. However, the exact mechanisms by which nephrolithiasis causes death remains unclear.

This is a preview of subscription content, access via your institution

Access options

Buy this article

  • Purchase on Springer Link
  • Instant access to full article PDF
Buy now

Prices may be subject to local taxes which are calculated during checkout

References

  1. Kum, F. et al. Do stones still kill? An analysis of death from stone disease 1999 to 2013 in England and Wales. BJU Int. http://dx.doi.org/10.1111/bju.13409 (2016).

  2. CDC/NCHS. Mortality by underlying and multiple cause, ages 18+: US, 1981–2013. knoema [online], (2015).

  3. Zisman, A. L., Evan, A. P., Coe, F. L. & Worcester, E. M. Do kidney stone formers have a kidney disease? Kidney Int. 88, 1240–1249 (2015).

    Article  Google Scholar 

  4. El-Zoghby, Z. M. et al. Urolithiasis and the risk of ESRD. Clin. J. Am. Soc. Nephrol. 7, 1409–1415 (2012).

    Article  Google Scholar 

  5. Lindell, A., Denneberg, T. & Granerus, G. Studies on renal function in patients with cystinuria. Nephron 77, 76–85 (1997).

    Article  CAS  Google Scholar 

  6. Edvardsson, V. O. et al. Hereditary causes of kidney stones and chronic kidney disease. Pediatr. Nephrol. 28, 1923–1942 (2013).

    Article  Google Scholar 

  7. Saran, R. et al. US renal data system 2014 annual data report: epidemiology of kidney disease in the United States. Am. J. Kidney Dis. 66, A7 (2015).

    Article  Google Scholar 

  8. Sakhaee, K. Epidemiology and clinical pathophysiology of uric acid kidney stones. J. Nephrol. 27, 241–245 (2014).

    Article  CAS  Google Scholar 

  9. Unsal, A. et al. Prediction of morbidity and mortality after percutaneous nephrolithotomy by using the Charlson Comorbidity Index. Urology 79, 55–60 (2012).

    Article  Google Scholar 

  10. Kreydin, E. I. & Eisner, B. H. Risk factors for sepsis after percutaneous renal stone surgery. Nat. Rev. Urol. 10, 598–605 (2013).

    Article  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Marcelino Rivera and Amy Krambeck are at the Department of Urology, Mayo Clinic, 200 1st Street SW, Rochester, Minnesota 55905, USA.,

    Marcelino Rivera & Amy Krambeck

Authors
  1. Marcelino Rivera
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Amy Krambeck
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Amy Krambeck.

Ethics declarations

Competing interests

The authors declare no competing financial interests.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Rivera, M., Krambeck, A. The dark side of stone disease — stones do still kill. Nat Rev Urol 13, 247–248 (2016). https://doi.org/10.1038/nrurol.2016.56

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/nrurol.2016.56

Search

Advanced search

Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing